Literature DB >> 19340399

Incidence of first primary central nervous system tumors in California, 2001-2005: children, adolescents and teens.

Monica Brown1, Rudolph Schrot, Katrina Bauer, Jennifer Dodge.   

Abstract

This study used data from the California Cancer Registry to comprehensively examine first primary central nervous system tumors (PCNST) by the International Classification of Childhood Cancers (ICCC) diagnostic groups and to compare their incidence by age groups, sex, race/ethnicity, socioeconomic status and tumor behavior. The study period, 2001-2005, represents the first 5 years of benign PCNST data collection in the state. The age-adjusted incidence rates were 2.1 for malignant and 1.3 for benign per 100,000. Children younger than 5 years old had the highest incidence of malignant PCNST (2.6 per 100,000). Teens aged 15-19 had the highest incidence of benign PCNST (1.8 per 100,000). Age-specific incidence rates were nearly the same for Hispanics, non-Hispanic whites, and Asian/Pacific Islanders for malignant PCNST among children younger than 5 (2.6-2.7 per 100,000); non-Hispanic whites had the highest rates in the 5-14 year-old age group (2.5 per 100,000) and Asian/Pacific Islanders the highest among the 15-19 year old age group (2.3 per 100,000). We found no statistically significant differences in the incidence of malignant PCNST by race/ethnicity in any age group. Astrocytoma had the highest incidence for both malignant and benign histology in most age groups.

Entities:  

Mesh:

Year:  2009        PMID: 19340399     DOI: 10.1007/s11060-009-9860-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  6 in total

Review 1.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

Review 2.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

3.  Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.

Authors:  Maryam Shabihkhani; Donatello Telesca; Masoud Movassaghi; Yalda B Naeini; Kourosh M Naeini; Seyed Amin Hojat; Diviya Gupta; Gregory M Lucey; Michael Ontiveros; Michael W Wang; Lauren S Hanna; Desiree E Sanchez; Sergey Mareninov; Negar Khanlou; Harry V Vinters; Marvin Bergsneider; Phioanh Leia Nghiemphu; Albert Lai; Linda M Liau; Timothy F Cloughesy; William H Yong
Journal:  J Neurooncol       Date:  2017-02-04       Impact factor: 4.130

4.  Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors.

Authors:  Emmanuel Desandes; Sandra Guissou; Pascal Chastagner; Brigitte Lacour
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

5.  Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.

Authors:  Courtney Duong; Thien Nguyen; John P Sheppard; Vera Ong; Lawrance K Chung; Daniel T Nagasawa; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

6.  Socioeconomic status and childhood central nervous system tumors in California.

Authors:  Stephen S Francis; Rong Wang; Catherine Enders; Isabel Prado; Joseph L Wiemels; Xiaomei Ma; Catherine Metayer
Journal:  Cancer Causes Control       Date:  2020-10-28       Impact factor: 2.532

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.